SC
PBH icon

Stephens Consulting’s Prestige Consumer Healthcare PBH Stock Holding History

Stephens Consulting’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10
Closed -$860 – 1753
2025
Q1 		$860 Buy
+10
New +$820 ﹤0.01% 712
2024
Q3 		– Sell
-56
Closed -$3.86K – 615
2024
Q2 		$3.86K Buy
+56
New +$3.79K ﹤0.01% 435

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stephens Consulting's PBH Position: Q2 2025 in Review

Stephens Consulting sold out of Prestige Consumer Healthcare (PBH) in Q2 2025, closing a stake of 10 shares — an estimated $860 sold.

Stephens Consulting first reported a position in PBH in Q2 2024 and held it in 2 quarters. The position peaked at $3.86K in Q2 2024. 378 funds tracked by Wall St. Rank hold PBH as of Q2 2025.

  • Stephens Consulting reported no remaining Prestige Consumer Healthcare position as of Q2 2025 after selling out during the quarter.
  • Stephens Consulting sold 10 Prestige Consumer Healthcare shares in Q2 2025, an estimated $860.
  • Stephens Consulting first reported a position in Prestige Consumer Healthcare in Q2 2024 and held it in 2 quarters.
  • Stephens Consulting's Prestige Consumer Healthcare position peaked at $3.86K in Q2 2024.
  • 378 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.